Evidence map›Paper›PMID 41214737›Full record

ArticleJournal of medical case reports2025

Ivermectin treatment for nasal myiasis complicated by orbital cellulitis: a case report.

Chakapan Promsopa, Jiratchaya Janprasert, Usaporn Prapaisit, Nichana Suwanparin

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chakapan PromsopaDivision of Allergy and Rhinology, Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. arrm012@gmail.com.ORCID http://orcid.org/0000-0002-3073-7789
Jiratchaya JanprasertDivision of Allergy and Rhinology, Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Usaporn PrapaisitDivision of Allergy and Rhinology, Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Nichana SuwanparinDivision of Allergy and Rhinology, Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNasal myiasis is a rare parasitic infestation caused by fly larvae, which can lead to serious complications, such as orbital cellulitis, if not treated promptly. Early recognition and intervention are essential to prevent further complications. CASE PRESENTATION: We present a case of a 55-year-old Thai female with advanced-stage malignant melanoma of the right nasal cavity, treated with endoscopic tumor removal and 3 months of concurrent chemoradiation. The patient developed nasal myiasis and orbital cellulitis secondary to maggot infestation. A multidisciplinary approach, including adjunctive therapy with ivermectin, resulted in the successful resolution of both the infestation and its complications.

conclusionThis case highlights the effectiveness of ivermectin in treating nasal myiasis and emphasizes the importance of a collaborative medical approach in managing complex cases. It also provides insights into the mechanism and clinical application of ivermectin for similar parasitic infestations.

Indexed as

Antiparasitic AgentsIvermectinMelanomaMyiasisNose DiseasesOrbital CellulitisAnimalsFemaleHumansMiddle AgedNose NeoplasmsTreatment OutcomeAntiparasitic AgentsIvermectinCase reportIvermectinMaggot infestationNasal myiasisOrbital cellulitis

Identifiers

PMID41214737
PMCPMC12604205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.